tiprankstipranks
Trending News
More News >
Cipher Pharmaceuticals (TSE:CPH)
TSX:CPH
Canadian Market

Cipher Pharmaceuticals (CPH) Financial Statements

Compare
88 Followers

Cipher Pharmaceuticals Financial Overview

Cipher Pharmaceuticals's market cap is currently C$384.10M. The company's EPS TTM is C$0.29226743909999997; its P/E ratio is 16.05; Cipher Pharmaceuticals is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is C$0.22. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 33.36M$ 21.16M$ 20.68M$ 21.94M$ 21.61M
Gross Profit$ 24.10M$ 17.09M$ 16.68M$ 18.26M$ 18.55M
Operating Income$ 7.85M$ 11.53M$ 12.04M$ 11.82M$ 12.20M
EBITDA$ 11.87M$ 11.53M$ 12.04M$ 13.66M$ 13.40M
Net Income$ 11.54M$ 20.38M$ 26.64M$ 7.76M$ 4.55M
Balance Sheet
Cash & Short-Term Investments$ 17.84M$ 39.83M$ 28.84M$ 20.55M$ 9.14M
Total Assets$ 162.51M$ 86.03M$ 73.78M$ 51.65M$ 44.28M
Total Debt$ 40.58M$ 353.00K$ 428.00K$ 516.00K$ 1.85M
Net Debt$ 22.74M$ -39.47M$ -28.41M$ -20.03M$ -7.29M
Total Liabilities$ 60.17M$ 5.51M$ 9.70M$ 12.75M$ 11.63M
Stockholders' Equity$ 102.34M$ 80.52M$ 64.08M$ 38.90M$ 32.64M
Cash Flow
Free Cash Flow$ 19.50M$ 15.98M$ 10.49M$ 13.81M$ 10.93M
Operating Cash Flow$ 19.55M$ 16.00M$ 10.57M$ 13.81M$ 11.69M
Investing Cash Flow$ -80.04M$ -144.00K$ -81.00K$ 0.00$ -760.00K
Financing Cash Flow$ 39.30M$ -5.24M$ -1.91M$ -2.47M$ -8.13M
Currency in USD

Cipher Pharmaceuticals Earnings and Revenue History

Cipher Pharmaceuticals Debt to Assets

Cipher Pharmaceuticals Cash Flow

Cipher Pharmaceuticals Forecast EPS vs Actual EPS